A
| Name | Dosage form | ATC code |
|---|---|---|
|
Alpha-tocopherol acetate (vitamin E) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 20 ml № 1 | A11HA03 |
|
Alpha-tocopherol acetate (vitamin E) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 20 ml № 1 | A11HA03 |
|
Alpha-tocopherol acetate (vitamin E) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
300 mg/ml, 20 ml № 1 | A11HA03 |
|
Aquavit-D3 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
375 mcg/ml, 10 ml № 1 | A11CC05 |
|
Ascorbic acid Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 2 ml № 10, № 100 | A11GA01 |
|
Ascorbic acid Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 2 ml № 10, № 100 | A11GA01 |
![]() Ascorbic acid Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg №50 | A11GA01 |
|
Ascorbic acid Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg № 100 | A11GA01 |
|
Ascorbic acid Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg № 50 | A11GA01 |
![]() Bisacodyl Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,01 g № 10 | A06AB02 |
![]() Carbacid Pechaevskiy Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A02AX |
![]() Dalmaxin Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,2 g № 5, № 10 | A05BA |
![]() Ergocalciferol (vitamin D2) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,125 %, 10 ml № 1 | A11CC01 |
![]() Glibenclamide Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 mg № 30 | А10ВВ01 |
![]() Heksavit Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
|
Kreazim 10000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
![]() Kreazim 20000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
|
|
2 ml № 5 | А11DВ |
![]() Leksadyl Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
10 mg № 10 | А06АВ02 |
![]() Lektac Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 10, № 20, № 30 | A02BA02 |
![]() Loperamide Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,002 g № 10, № 20 | A07DA03 |
|
Methovitan Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 hard capsules | А11АВ |
![]() Methyluracil Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,5 g, № 5 ,№ 10 | A14B |
![]() Nevrolek Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml № 5 | A11DB |
![]() No-H-Sha Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/mg, 2 ml in ampoules № 5 | A03AD02 |
![]() No-H-Sha Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10 | A03AD02 |
![]() No-H-Sha Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10, № 30 | A03A D02 |
![]() No-H-Sha forte Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,08 g № 30 | A03AD02 |
![]() Ondansetron Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 2 ml № 5 | A04AA01 |
![]() Ondansetron Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 4 ml № 5 | A04AA01 |
![]() Ondansetron Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
4 mg № 10 | A04AA01 |
![]() Ondansetron Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
8 mg № 10 | A04AA01 |
|
Pancreatin 8000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, №50 | A09AA02 |
![]() Pancreazim Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | A09AA02 |
![]() Pancreazim 10000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
![]() Pancreazim 10000 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
![]() Papaverine Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/ml, 2 ml № 10 | A03AD01 |
![]() Pyridoxine hydrochloride (vitamin В6) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml № 10 | A11HA02 |
![]() Ranitidine Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg №30 | A02BA02 |
![]() Ranitidine Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 20 | A02BA02 |
![]() Renalgan Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 ml №5 | A03DA02 |
![]() Renalgan Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 10 | A03DA02 |
![]() Renalgan Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml №10 | A03DA02 |
![]() Renalgan Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№20 | A03DA02 |
![]() Retinol acetate (vitamin A) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
34,4 mg/ml, 10 ml № 1 | A11CA01 |
![]() Revit Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 75, № 100 | A11BA |
![]() Solizym forte Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA |
![]() Stomolik Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
125 ml № 1 | А01АВ12 |
![]() Thiamine chloride (vitamin В1) Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml in ampoules № 10 | A11DA01 |






































